secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001193125-22-308372
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare amends bylaws to update director nomination and proxy solicitation requirements
--------------------------------------------------------------------------------

- Board adopted Third Amended and Restated Bylaws effective December 19, 2022.
- Amendment revises Article II, Section 11 to require compliance with SEC Rule 14a-19 for director nominations and proxy solicitations.
- Technical, ministerial, and conforming changes made to align with recent Delaware General Corporation Law amendments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312522308372/0001193125-22-308372-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312522308372/d385362d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-308372

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer